Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06470191 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06470191 · ClinicalTrials.gov record · last posted 2026-05-05

A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.

StatusRecruiting
PhasePhase 2/3
Started2024-07-30
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
To evaluate the efficacy and safety of B007 in the Treatment of Primary Membranous Nephropathy

Amendment record 5 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 5 times since 2024-06-21; most recent amendment 2026-04-29. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2024-08-04
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT06470191
Lead Sponsor Shanghai Jiaolian Drug Research and Development Co., Ltd
Collaborators: Shanghai Pharmaceuticals Holding Co., Ltd
Conditions Primary Membranous Nephropathy
Enrollment 216 participants
Start Date 2024-07-30
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-05